July 2000 Cover
|
 |
French researchers have found that HIV-infected patients with cytomegalovirus (CMV) infection in the central nervous system can benefit from therapy with foscarnet and ganciclovir. The study involved 31 HIV patients
who received the drugs intravenously two times a day during the induction therapy and then once a day during maintenance therapy.
According to the researchers, induction therapy caused clinical improvement or stabilization in nearly 75 percent of the patients. The researchers note that the overall median survival time was 94 days,
while patients who received maintenance therapy lived a median of 119 days.
Editor's Note: from Reuters Health Info Services
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
